Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06626386
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-02
Brief Title:
Determination of Prostate-specific Antigen in Capillary Blood PSA-Cap
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Determination of Prostate-specific Antigen in Capillary Blood PSA-Cap
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PSA-Cap
Brief Summary:
The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients Furthermore a stability test of the samples is carried out after storage at room temperature for 24 7296 and 168 hours Particular attention is paid to the comparability of the measurement results and the influence of the transportation time
Detailed Description:
Interventions that are conducted with the PSA-Cap trial are the collection of capillary blood 6 droplets from the fingertip during regular PSA testing in venous blood PSA is measured in the serum fraction of both samples capillary and venous using the established routine procedure either immediately or after simulation of common transport conditions intermediate storage for 24 7296 h and 168 h at 22 C Control measurements include parameters of cell lysis LDH HIL check and general protein stability albumin The patient samples used are anonymized at the source by means of a consecutive series of numbers The anonymized result groups are compared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None